Dark Forest Capital Management’s Filana Therapeutics FLNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-10,635
Closed -$131K 1128
2024
Q2
$131K Buy
+10,635
New +$224K 0.02% 605
2023
Q4
Sell
-10,264
Closed -$171K 990
2023
Q3
$171K Buy
10,264
+994
+11% +$19.7K 0.01% 1026
2023
Q2
$227K Buy
9,270
+7,892
+573% +$190K 0.02% 905
2023
Q1
$33.2K Buy
+1,378
New +$38.2K 0.01% 903

Other funds holding FLNA

Dark Forest Capital Management's FLNA Position: Q3 2024 in Review

Dark Forest Capital Management sold out of Filana Therapeutics (FLNA) in Q3 2024, closing a stake of 10,635 shares — an estimated $131K sold.

Dark Forest Capital Management first reported a position in FLNA in Q1 2023 and held it in 4 quarters. The position peaked at $227K in Q2 2023. 161 funds tracked by Wall St. Rank hold FLNA as of Q3 2024.

  • Dark Forest Capital Management reported no remaining Filana Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Dark Forest Capital Management sold 10,635 Filana Therapeutics shares in Q3 2024, an estimated $131K.
  • Dark Forest Capital Management first reported a position in Filana Therapeutics in Q1 2023 and held it in 4 quarters.
  • Dark Forest Capital Management's Filana Therapeutics position peaked at $227K in Q2 2023.
  • 161 funds tracked by Wall St. Rank held Filana Therapeutics as of Q3 2024.

Based on Dark Forest Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.